J
Jonas Manjer
Researcher at Lund University
Publications - 384
Citations - 26240
Jonas Manjer is an academic researcher from Lund University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 84, co-authored 369 publications receiving 23177 citations. Previous affiliations of Jonas Manjer include Uppsala University & Malmö University.
Papers
More filters
Journal ArticleDOI
Circulating sex hormones and breast cancer risk factors in postmenopausal women: Reanalysis of 13 studies
Timothy J. Key,P N Appleby,Gillian K Reeves,Andrew W. Roddam,Andrew W. Roddam,Kathy J. Helzlsouer,Kathy J. Helzlsouer,Anthony J. Alberg,Anthony J. Alberg,Dana E. Rollison,Joanne F. Dorgan,Louise A. Brinton,Kim Overvad,Rudolf Kaaks,Antonia Trichopoulou,Françoise Clavel-Chapelon,Salvatore Panico,Eric J. Duell,Petra H.M. Peeters,Petra H.M. Peeters,S. Rinaldi,S. Rinaldi,Ian S. Fentiman,Mitch Dowsett,Jonas Manjer,Per Lenner,Göran Hallmans,Laura Baglietto,Dallas R. English,Graham G. Giles,John L. Hopper,Gianluca Severi,Howard A. Morris,Susan E. Hankinson,Shelley S. Tworoger,Karen L. Koenig,Anne Zeleniuch-Jacquotte,Alan A. Arslan,Paolo Toniolo,Roy E. Shore,Vittorio Krogh,Andrea Micheli,Franco Berrino,Elizabeth Barrett-Connor,Gail A. Laughlin,Michinori Kabuto,Suminori Akiba,Richard G. Stevens,Kazuo Neriishi,Charles E. Land,J. A. Cauley,Li Yung Lui,Steven R. Cummings,Marc J. Gunter,T E Rohan,Howard D. Strickler +55 more
TL;DR: Sex hormone concentrations were strongly associated with several established or suspected risk factors for breast cancer, and may mediate the effects of these factors on breast cancer risk.
Journal ArticleDOI
Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study
TL;DR: Conclusions on over-diagnosis of breast cancer in the Malmö mammographic screening trial can be drawn mainly for women aged 55-69 years at randomisation whose control groups were never screened.
Journal ArticleDOI
Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).
Alan A. Arslan,Kathy J. Helzlsouer,Charles Kooperberg,Xiao-Ou Shu,Emily Steplowski,H. Bas Bueno-de-Mesquita,Charles S. Fuchs,Myron D. Gross,Eric J. Jacobs,Andrea Z. LaCroix,Gloria M. Petersen,Rachael Z. Stolzenberg-Solomon,Wei Zheng,Demetrius Albanes,Laufey T. Amundadottir,William R. Bamlet,Aurelio Barricarte,Sheila Bingham,Heiner Boeing,Marie-Christine Boutron-Ruault,Julie E. Buring,Stephen J. Chanock,Sandra Clipp,J. Michael Gaziano,Edward Giovannucci,Susan E. Hankinson,Patricia Hartge,Robert N. Hoover,David J. Hunter,Amy Hutchinson,Amy Hutchinson,Kevin B. Jacobs,Kevin B. Jacobs,Peter Kraft,Shannon M. Lynch,Jonas Manjer,JoAnn E. Manson,Anne McTiernan,Robert R. McWilliams,Julie B. Mendelsohn,Dominique S. Michaud,Domenico Palli,Thomas E. Rohan,Nadia Slimani,Gilles Thomas,Anne Tjønneland,Geoffrey S. Tobias,Dimitrios Trichopoulos,Dimitrios Trichopoulos,Jarmo Virtamo,Brian M. Wolpin,Kai Yu,Anne Zeleniuch-Jacquotte,Alpa V. Patel +53 more
TL;DR: Findings provide strong support for a positive association between BMI and pancreatic cancer risk and suggest centralized fat distribution may increase pancreatic cancers risk, especially in women.
Journal ArticleDOI
Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer
Aimée R. Kreimer,Mattias Johansson,Tim Waterboer,Rudolf Kaaks,Jenny Chang-Claude,Dagmar Drogen,Anne Tjønneland,Kim Overvad,J. Ramón Quirós,Carlos A. González,María José Sánchez,Nerea Larrañaga,Carmen Navarro,Aurelio Barricarte,Ruth C. Travis,Kay-Tee Khaw,Nicholas J. Wareham,Antonia Trichopoulou,Antonia Trichopoulou,Pagona Lagiou,Pagona Lagiou,Pagona Lagiou,Dimitrios Trichopoulos,Petra H.M. Peeters,Salvatore Panico,Giovanna Masala,Sara Grioni,Rosario Tumino,Paolo Vineis,H. Bas Bueno-de-Mesquita,Göran Laurell,Göran Hallmans,Jonas Manjer,Johanna Ekström,Guri Skeie,Eiliv Lund,Elisabete Weiderpass,Pietro Ferrari,Graham Byrnes,Isabelle Romieu,Elio Riboli,Allan Hildesheim,Heiner Boeing,Michael Pawlita,Paul Brennan +44 more
TL;DR: The increased risk of oropharyngeal cancer among HPV16 E6 seropositive participants was independent of time between blood collection and diagnosis and was observed more than 10 years before diagnosis.
Journal ArticleDOI
Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? : Results from the EPIC study
Dora Romaguera,Anne-Claire Vergnaud,Petra H.M. Peeters,Petra H.M. Peeters,Carla H. van Gils,Doris S. M. Chan,Pietro Ferrari,Isabelle Romieu,Mazda Jenab,Nadia Slimani,Françoise Clavel-Chapelon,Françoise Clavel-Chapelon,Guy Fagherazzi,Guy Fagherazzi,Florence Perquier,Florence Perquier,Rudolf Kaaks,Birgit Teucher,Heiner Boeing,Anne Von Rüsten,Anne Tjønneland,Anja Olsen,Christina C. Dahm,Kim Overvad,José Ramón Quirós,Carlos González,María José Sánchez,Carmen Navarro,Aurelio Barricarte,Miren Dorronsoro,Kay-Tee Khaw,Nicholas J. Wareham,Francesca L. Crowe,Timothy J. Key,Antonia Trichopoulou,Pagona Lagiou,Pagona Lagiou,Pagona Lagiou,Christina Bamia,Giovanna Masala,Paolo Vineis,Rosario Tumino,Sabina Sieri,Salvatore Panico,Anne M. May,H. Bas Bueno-de-Mesquita,Frederike L. Büchner,Elisabet Wirfält,Jonas Manjer,Ingegerd Johansson,Göran Hallmans,Guri Skeie,Kristin Benjaminsen Borch,Christine L. Parr,Elio Riboli,Teresa Norat +55 more
TL;DR: Adherence to the WCRF/AICR recommendations for cancer prevention may lower the risk of developing most types of cancer.